Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer
Lianyu Chen, Chien‐shan Cheng, Chao Qu, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 500, Iss. 3, pp. 691-697
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Mechanisms of Polycomb group protein function in cancer
Victoria Parreno, Anne‐Marie Martinez, Giacomo Cavalli
Cell Research (2022) Vol. 32, Iss. 3, pp. 231-253
Open Access | Times Cited: 103
Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine
Shangnan Dai, Yunpeng Peng, Yi Zhu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109521-109521
Open Access | Times Cited: 80
Fructose-1,6-bisphosphatase 1 in cancer: Dual roles, mechanistic insights, and therapeutic potential – A comprehensive review
Qinghang Song, Jiehe Sui, Yuxuan Yang, et al.
International Journal of Biological Macromolecules (2025), pp. 139273-139273
Closed Access | Times Cited: 1
Heterochromatin protein 1 (HP1): interactions with itself and chromatin components
Amarjeet Kumar, Hidetoshi Kono
Biophysical Reviews (2020) Vol. 12, Iss. 2, pp. 387-400
Open Access | Times Cited: 63
CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma
Xiaoping Zhong, Anna Kan, Wancong Zhang, et al.
Aging (2019) Vol. 11, Iss. 15, pp. 5483-5497
Open Access | Times Cited: 55
Glycolysis in the progression of pancreatic cancer.
Xinyao Chang, Xingchen Liu, Haoze Wang, et al.
PubMed (2022) Vol. 12, Iss. 2, pp. 861-872
Closed Access | Times Cited: 30
CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis
Shupeng Zhao, Fan Wang, Ming Yang, et al.
Journal of Neuro-Oncology (2019) Vol. 145, Iss. 1, pp. 35-48
Closed Access | Times Cited: 46
CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma
Chao Ma, Xing‐Guo Nie, Yanli Wang, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 45
TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer
Lei Li, Yuan Yu, Zhengle Zhang, et al.
Pharmacological Research (2021) Vol. 166, pp. 105429-105429
Closed Access | Times Cited: 33
CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression
Wen Peng, Shuang Shi, Jiacheng Zhong, et al.
Oncogene (2022) Vol. 41, Iss. 22, pp. 3051-3063
Closed Access | Times Cited: 24
The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis
Chien‐Hsiu Li, Ming‐Hsien Chan, Yu‐Chan Chang
Aging (2022) Vol. 14, Iss. 7, pp. 3233-3258
Open Access | Times Cited: 23
USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1.
Chong Yang, Shikai Zhu, Hongji Yang, et al.
PubMed (2019) Vol. 9, Iss. 8, pp. 1722-1733
Closed Access | Times Cited: 42
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Leticia Colyn, Gloria Álvarez‐Sola, María U. Latasa, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
m5C modification of LINC00324 promotes angiogenesis in glioma through CBX3/VEGFR2 pathway
Aini Pan, Yixue Xue, Xuelei Ruan, et al.
International Journal of Biological Macromolecules (2023) Vol. 257, pp. 128409-128409
Closed Access | Times Cited: 12
Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review)
Jian Wang, Bo Yang, Xiu‐Hang Zhang, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 3
Open Access | Times Cited: 11
Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression
Ayoola O. Ogunleye, Rama Krishna Nimmakayala, Surinder K. Batra, et al.
Stem Cells (2023) Vol. 41, Iss. 5, pp. 417-430
Closed Access | Times Cited: 11
The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance
Mengmeng Wang, Xiaoju Huang, Dan Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Deletion of ENO1 sensitizes pancreatic cancer cells to gemcitabine via MYC/RRM1-mediated glycolysis
Yegang Lü, Hongqin Ma, Xiaoxiao Xiong, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
NCAPG is transcriptionally regulated by CBX3 and activates the Wnt/β-catenin signaling pathway to promote proliferation and the cell cycle and inhibit apoptosis in colorectal cancer
Hong Yang, Leilei Pu, Ruobing Li, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 2, pp. 900-912
Open Access | Times Cited: 10
PSMC4 promotes prostate carcinoma progression by regulating the CBX3–EGFR‐PI3K‐AKT‐mTOR pathway
Kaifeng Liu, Shengmin Zhang, Yongzhan Gong, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 16, pp. 2437-2447
Open Access | Times Cited: 9
Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer
Xin Li, Yan Du, Wenkai Jiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Heterochromatin Protein 1: A Multiplayer in Cancer Progression
Yu Hyun Jeon, Go Woon Kim, So Yeon Kim, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 763-763
Open Access | Times Cited: 15
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Hongjuan Niu, Peiqiong Chen, Lu Fan, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 15
LncRNA TYMSOS facilitates breast cancer metastasis and immune escape through downregulating ULBP3
Kejing Zhang, Xiao‐Lang Tan, Lei Guo
iScience (2023) Vol. 26, Iss. 9, pp. 107556-107556
Open Access | Times Cited: 7
lncRNA-SNHG17 promotes colon adenocarcinoma progression and serves as a sponge for miR-375 to regulate CBX3 expression.
Jia Liu, Zhan Yang, Jiefu Wang, et al.
PubMed (2020) Vol. 12, Iss. 9, pp. 5283-5295
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top